From April 1, 2023 to June 30, 2023, the company has repurchased 159,920 shares, representing 1.95% for $0.58 million. With this, the company has completed the repurchase of 385,140 shares, representing 4.66% for $1.53 million under the buyback announced on August 16, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.02 USD | +0.66% | -0.66% | -5.03% |
03-07 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-07 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.03% | 24.35M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- LUMO Stock
- News Lumos Pharma, Inc.
- Tranche Update on Lumos Pharma, Inc.'s Equity Buyback Plan announced on August 16, 2022.